Farmacopea De Los Estados Unidos Mexicanos [verified] -
Reconociendo la relevancia de esta práctica terapéutica en México, se publica la , cuya 4ª edición fue lanzada en 2023. En ella se consignan los procedimientos de preparación, métodos de análisis y especificaciones para las sustancias y productos homeopáticos.
Following the first edition, subsequent editions were published in 1874, 1896, and 1904 by various scientific societies. A critical turning point came on , when President Plutarco Elías Calles issued a decree making the existence of a national pharmacopoeia a formal obligation of the Mexican State. This led to the publication in 1930 of the Farmacopea Nacional de los Estados Unidos Mexicanos . Further editions followed in 1952, 1962, and 1974, each incorporating new monographs and analytical methods.
Farmacopea de los Estados Unidos Mexicanos (FEUM) is much more than a list of medicines; it is the official "scientific constitution" for health in Mexico, issued by the Ministry of Health.
The is the definitive official compendium in Mexico that establishes the standards for the identity, purity, and quality of medicines, raw materials, medical devices, and herbal remedies. Regulated and published by the Secretaría de Salud (Ministry of Health) through the Comisión Permanente de la Farmacopea de los Estados Unidos Mexicanos (CPFEUM) , the FEUM is the legal benchmark ensuring that healthcare products in the country are safe, effective, and manufactured to the highest global standards. It plays an indispensable role in the Mexican healthcare system, public health monitoring, and the broader pharmaceutical industry. 1. Historical Background and Evolution farmacopea de los estados unidos mexicanos
: The Comisión Permanente de la Farmacopea de los Estados Unidos Mexicanos (CPFEUM), supported by COFEPRIS , is responsible for its constant review and update.
La FEUM es el documento oficial expedido por la Secretaría de Salud que establece los requisitos mínimos de calidad que deben cumplir los medicamentos, sustancias oficinales, fármacos, aditivos y dispositivos médicos que se comercializan en territorio mexicano.
While challenges like update lag and resource constraints persist, ongoing harmonization with international pharmacopoeias and digital modernization are strengthening its role in ensuring safe, effective, and high-quality medicines for the Mexican population. Reconociendo la relevancia de esta práctica terapéutica en
The first "Farmacopea Mexicana" was published in 1846 , driven by scientific nationalism following Mexico's independence.
: La Norma Oficial Mexicana NOM-001-SSA1-2020 institucionaliza la estructura interna de la farmacopea, estableciendo además los lineamientos oficiales para sus fases de consulta pública, revisión periódica, edición y venta.
: Se ofrecen guías para la interpretación de las monografías, el manejo de los productos farmacéuticos y los requisitos regulatorios. A critical turning point came on , when
The official Mexican Standard , titled "Which institutes the structure of the Pharmacopoeia of the United Mexican States and its supplements and the procedure for its revision, updating, edition and diffusion," is the foundational legal instrument that governs the FEUM. This NOM establishes the guidelines for how the FEUM is structured, how it is revised and updated, and how it is officially published and disseminated. It mandates a biennial review and update process, ensuring the FEUM remains current.
The is the official compendium of drug substance and drug product quality standards for Mexico. It establishes the mandatory technical and scientific requirements for all medicines, pharmaceutical raw materials, medical devices, and other health-related inputs manufactured, imported, distributed, or sold in Mexican territory.
A landmark year for Mexican pharmacy and public health was . In that year, the Academia Farmacéutica in Mexico City published the first Farmacopea Mexicana , led by renowned figures like Dr. Leopoldo Río de la Loza and Dr. José María Vargas. This was a revolutionary step; it was the second pharmacopoeia to be published in the entire American continent , following only the United States Pharmacopeia (1820). Remarkably, it predates many prestigious European pharmacopoeias. Its primary goal was to replace the use of foreign standards with one that was attuned to the realities and medicinal resources of the young Mexican nation.